![](https://monteverdelaw.com/wp-content/uploads/dcph-logo-registered-rgb.jpg)
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), relating to its proposed merger with ONO Pharmaceutical Co., Ltd. Under the terms of the agreement, ONO will acquire all outstanding shares of Deciphera common stock for $25.60 per share in cash through a tender offer.